ATARA BIOTHERAPEUTICS, INC. Severance Costs
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Severance Costs of $800.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2026-08-12
- ATARA BIOTHERAPEUTICS, INC. severance costs for the quarter ending 2026-06-30 was $800.00K, a 46.67% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. severance costs for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. severance costs for the quarter ending 2025-06-30 was $1.50M.
- ATARA BIOTHERAPEUTICS, INC. severance costs for the quarter ending 2025-03-31 was $9.80M.
- ATARA BIOTHERAPEUTICS, INC. severance costs for fiscal 2025 was $300.00K.
| Period end | Severance Costs 1 month | Severance Costs 3 month | Severance Costs 6 month | Severance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $800.00K 10-Q · filed 2026-08-12 | $800.00K 10-Q · filed 2026-08-12 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-12 | |||
| 2025-12-31 | $300.00K 10-K · filed 2026-03-16 | |||
| 2025-10-31 | $1.20M 10-K · filed 2026-03-16 | |||
| 2025-06-30 | $1.50M 10-Q · filed 2026-08-12 | $11.30M 10-Q · filed 2026-08-12 | ||
| 2025-05-31 | $1.40M 10-K · filed 2026-03-16 | |||
| 2025-03-31 | $2.70M 10-K · filed 2026-03-16 | $9.80M 10-Q · filed 2026-05-12 | ||
| 2025-01-31 | $7.10M 10-Q · filed 2025-11-12 | |||
| 2024-01-31 | $5.10M 10-K · filed 2026-03-16 | |||
| 2023-11-30 | $6.70M 10-K · filed 2026-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |